Interleukin-15 modulates interferon-γ and β-chemokine production in patients with HIV infection: implications for immune-based therapy
暂无分享,去创建一个
G. d’Ettorre | V. Vullo | M. Lichtner | C. Mastroianni | G. Ceccarelli | L. Scorzolini | M. Carnevalini | A. Massetti | C. D'Agostino | G. Forcina | Martina Carnevalini
[1] A. Telenti,et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. , 2003, Archives of internal medicine.
[2] J. Altman,et al. IL-15 enhances survival and function of HIV-specific CD8+ T cells. , 2003, Blood.
[3] C. Chougnet,et al. The role of antigen-presenting cells in HIV pathogenesis , 2002, Current infectious disease reports.
[4] G. d’Ettorre,et al. Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients , 2002, AIDS.
[5] D. Nickle,et al. Evidence for Human Immunodeficiency Virus Type 1 Replication In Vivo in CD14+ Monocytes and Its Potential Role as a Source of Virus in Patients on Highly Active Antiretroviral Therapy , 2002, Journal of Virology.
[6] G. d’Ettorre,et al. Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection. , 2000, Blood.
[7] S. Crowe,et al. HIV‐1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication , 2000, Journal of leukocyte biology.
[8] M. Lederman,et al. Immune restoration with antiretroviral therapies: implications for clinical management. , 2000, JAMA.
[9] K. Rosenthal,et al. RANTES production by T cells and CD8-mediated inhibition of human immunodeficiency virus gene expression before initiation of potent antiretroviral therapy predict sustained suppression of viral replication. , 2000, The Journal of infectious diseases.
[10] T. Waldmann,et al. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. , 1999, Journal of immunology.
[11] J. Moore,et al. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses. , 1999, The Journal of infectious diseases.
[12] A. Fauci,et al. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. , 1998, The Journal of clinical investigation.
[13] H von Briesen,et al. Individual cell analysis of the cytokine repertoire in human immunodeficiency virus-1-infected monocytes/macrophages by a combination of immunocytochemistry and in situ hybridization. , 1998, Blood.
[14] E A Emini,et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. , 1997, The New England journal of medicine.
[15] J. Levy,et al. Do beta-chemokines have clinical relevance in HIV infection? , 1997, The Journal of clinical investigation.
[16] I. Frank,et al. IL-15 enhances immune functions during HIV infection. , 1997, Journal of immunology.
[17] E. R. Stiehm,et al. Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: enhancement with interleukin-2(IL-2), IL-12, and IL-15. , 1997, Clinical immunology and immunopathology.
[18] N. Letvin,et al. IL-15 stimulates the expansion of AIDS virus-specific CTL. , 1996, Journal of immunology.
[19] I P Keet,et al. Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV-infected individuals: decreased IFN-gamma in the presence of preserved IL-4 production. , 1996, Journal of immunology.
[20] M. Lederman,et al. Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression. , 1996, The Journal of clinical investigation.
[21] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[22] J. Berzofsky,et al. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15 , 1995, The Journal of experimental medicine.
[23] R. Dubose,et al. Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. , 1995, The EMBO journal.
[24] D. Cosman,et al. Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15. , 1994, The EMBO journal.
[25] A. Lazzarin,et al. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV‐infected patients , 1994, AIDS.
[26] V. Fung,et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. , 1994, Science.
[27] K. D. Jakobsen,et al. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway. , 1989, Journal of immunology.
[28] M. Caligiuri,et al. Interleukin 15: biology and relevance to human disease. , 2001, Blood.
[29] Lane Hc,et al. Cytokine-based therapies for HIV infection. , 2001 .
[30] T. Waldmann,et al. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. , 1999, Annual review of immunology.